NAV
$44.18
AUM
$83.3M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.98
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +5.85% | +3.50% | +6.86% | +16.33% | +14.40% | +8.01% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ROP.SW | Roche Holding AG Ordinary Shares new | 13.21% |
| 2 | NOVN.SW | Novartis AG Registered Shares | 12.91% |
| 3 | NESN.SW | Nestle SA | 11.69% |
| 4 | ABBN.SW | ABB Ltd | 7.62% |
| 5 | UBSG.SW | UBS Group AG Registered Shares | 5.29% |
| 6 | CFR.SW | Compagnie Financiere Richemont SA Class A | 4.41% |
| 7 | ZURN.SW | Zurich Insurance Group AG | 3.98% |
| 8 | HOLN.SW | Holcim Ltd | 2.61% |
| 9 | LONN.SW | Lonza Group Ltd | 2.38% |
| 10 | SREN.SW | Swiss Re AG | 2.28% |
Under normal market conditions, the fund invests at least 80% of its assets in the component securities of the FTSE Switzerland Capped Index and in depositary receipts representing such securities. The FTSE Switzerland Capped Index is based on the FTSE Switzerland Index and is designed to measure the performance of Swiss large- and mid-capitalization stocks. The fund is non-diversified.
Inception Date: 2018-02-06